Search Results - "Papa, Melina del"
-
1
A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study
Published in Graefe's archive for clinical and experimental ophthalmology (01-06-2022)“…Background Benzalkonium chloride (BAK), the most commonly used preservative in anti-glaucoma eye drops, inflicts damage to the ocular surface. A novel…”
Get full text
Journal Article -
2
Hyaluronate Protects From Benzalkonium Chloride-Induced Ocular Surface Toxicity
Published in Translational vision science & technology (21-10-2024)“…The purpose of this study was to investigate the effect of sodium hyaluronate (SH) on benzalkonium chloride (BAK)-induced toxicity in the ocular surface…”
Get full text
Journal Article -
3
Osmoprotective and bioprotective effect of threalose 3% under desiccating conditions: An in vitro study
Published in Acta ophthalmologica (Oxford, England) (01-12-2022)“…Purpose: To study the osmoprotective and bioprotective effect of trehalose 3% during desiccation conditions. Methods: Normal human conjunctival epithelial…”
Get full text
Journal Article -
4
In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity
Published in Acta ophthalmologica (Oxford, England) (01-12-2022)“…Purpose: To evaluate the protective effect of different concentrations of sodium hyaluronate (SH) on the Benzalkonium chloride (BAK)‐induced toxicity using an…”
Get full text
Journal Article -
5
Cytotoxicity evaluation of a novel latanoporst 0.005% nanoemulsion
Published in Acta ophthalmologica (Oxford, England) (01-01-2022)“…Purpose To evaluate the cytotoxicity of a new Latanoprost Benzalkonium chloride (BAK)‐free nanoemulsion and to compare it with a Latanoprost solution…”
Get full text
Journal Article -
6
A comparative study of difluprednate 0.05% nanoemulsion vs prednisolone acetate 1% + phenylephrine 0.12% suspension on postoperative inflammation treatment following cataract surgery
Published in Acta ophthalmologica (Oxford, England) (01-01-2022)“…Purpose To investigate if Difluprednate 0.05% nanoemulsion (DIFL) administered once a day (BID) is non‐inferior than Prednisolone acetate 1% + Phenylephrine…”
Get full text
Journal Article -
7
Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Published in Re:GEN open (01-01-2021)“…Purpose: To assess the effectiveness and tolerability of a new latanoprost 0.005% benzalkonium chloride (BAK)-free nanoemulsion. Methods : A nonrandomized…”
Get full text
Journal Article -
8
Evaluation of the osmoprotective and bioprotective effect of trehalose 3
Published in The Pan-American journal of ophthalmology (01-12-2023)“…Purpose: The purpose of this study was to study the osmoprotective and bioprotective effect of trehalose 3% + carboxymethylcellulose (CMC) 0.5% during…”
Get full text
Journal Article -
9
Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial
Published in Journal of cataract and refractive surgery (01-07-2022)“…PURPOSETo establish whether difluprednate 0.05% nanoemulsion (DIFL) twice a day is as effective as prednisolone acetate 1% + phenylephrine hydrochloride 0.12%…”
Get full text
Journal Article -
10
Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
Published in Clinical ophthalmology (Auckland, N.Z.) (30-11-2023)“…Purpose: To study the efficacy and toxic effects of bepotastine besilate 1.5% preservative-free (BB-PF) and olopatadine 0.2% BAKpreserved (OL-BAK) drops on the…”
Get full text
Journal Article -
11
Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2023)“…PurposeTo study the efficacy and toxic effects of bepotastine besilate 1.5% preservative-free (BB-PF) and olopatadine 0.2% BAK-preserved (OL-BAK) drops on the…”
Get full text
Report